Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 17 - Drugs for dermatological disorders
Patents for A61P 17 - Drugs for dermatological disorders (106,455)
11/2007
11/28/2007EP1858544A2 Il-10 related peptides for wound healing
11/28/2007EP1858526A1 Glycoalkaloid and tlr agonist combinations and various uses thereof
11/28/2007EP1858503A1 Topical gels compositions
11/28/2007EP1765356B1 Spray composition comprising a combination of calcitriol and clobetasol propionate, an alcoholic phase, at least one volatile silicone and one non volatile oily phase
11/28/2007EP1458395B1 Medical use of gsk3-inhibiting oxindole derivatives
11/28/2007EP1373257B1 Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases
11/28/2007EP1315718B1 Bicyclic heterocycles, medicaments containing these compounds, their use, and methods for the production thereof
11/28/2007EP0937103B1 Compounds and methods for modulating cell adhesion
11/28/2007CN101077881A 1-O-beta-D-glucopyranosylgeraniol-10,5-olide and use thereof
11/28/2007CN101077875A Boronic ester and acid compounds, synthesis and uses
11/28/2007CN101077438A Medicine liquid magnetotherapeutic device for treating skin disease and its manufacturing method
11/28/2007CN101077387A Traditional Chinese medicine pilatory
11/28/2007CN101077362A Plant-type skin mucosa disinfecting agent
11/28/2007CN101077361A External applied Traditional Chinese medicine powder medicine for dewatering, anti-inflammation and pain-relieving
11/28/2007CN101077360A Medicinal composition for treating sugar diabetes skin ulcer and preparation method thereof
11/28/2007CN101077359A Skin healthy powder
11/28/2007CN100351259C Sulfur-containing phospholipid derivatives
11/28/2007CN100351255C Metal substituted non centrosimmetrical phthalocyanine analogues, their preparation and use in photodynamic therapy and in vivo diagnostic
11/28/2007CN100351253C Pyrrolo [2,3-d] pyrimidine compounds as immunosuppressive agents
11/28/2007CN100351250C Nobel compounds having selective inhibiting effect at GSK3
11/28/2007CN100351245C Oxa- and thiadiazoles and their use as metalloproteinase inhibitors
11/28/2007CN100351244C Bis-aromatic alkanols
11/28/2007CN100351237C Novel hererocyclic compound and preparation thereof and medicine composition containing same and use thereof in medicine
11/28/2007CN100351230C Urea of N-heterocyclic carboxylic acid or the isostere of carboxylic acid and aminocarboxylic acid ester
11/28/2007CN100350969C Medicine to be taken after being mixed in liquor of possessing bearutified and-faced effects
11/28/2007CN100350962C Vifiligo pill
11/28/2007CN100350957C Composition for curing psoriasis
11/28/2007CN100350951C External-applied medicine for treating burn, valnus and local tumor inflammation
11/28/2007CN100350949C Freckle removing medicine
11/28/2007CN100350934C Baidianxiao treaditional Chinese medicine for treating vitiligo and preparation method thereof
11/28/2007CN100350930C External-application Chinese medicine for treating psoriasis
11/28/2007CN100350926C Medicine for treating acne and its preparing method
11/28/2007CN100350921C Dermatosis eliminating medicine
11/28/2007CN100350918C Medicinal liquor for treating burns, scalds and skin disease
11/28/2007CN100350905C Treatment of burns
11/27/2007US7301023 Immunosuppressants; grafting of organs; rheumatic diseases
11/27/2007US7300952 NF-κb inhibitors
11/27/2007US7300935 Gonadotropin-releasing hormone antagonistic activity, therapy of prostatic cancer, endometriosis, precocious puberty; N-(4-(1-(2,6-difluorobenzyl)-5-(((2-ethoxyethyl)(methyl)amino)methyl)-2,4-dioxo-3-(2-pyridinyl)-1,2,3,4-tetrahydrothieno[2,3-d]pyrimidin-6-yl)phenyl)-N'-methoxyurea
11/27/2007US7300933 Diazabicyclic biaryl derivatives
11/27/2007US7300925 treating psoriasis with e.g. 19-nor-2beta-ethyl-1alpha,25-dihydroxyvitamin D3
11/27/2007US7300917 Remedy for chronic disease
11/27/2007US7300916 Use of an erythropoietin antagonist for manufacture of a pharmaceutical preparation for preventing and/or treating hypertrophic scars, keloid or chronic arthritic diseases.
11/27/2007US7300669 Fatty alcohol, skin conditioner, propylene glycol, mineral oil or white soft paraffin and water; fluticasone propionate and oil in water emulsion includig excipients; antiinflammatory agents
11/27/2007US7300663 Adhesion and sealing of tissue with compositions containing polyfunctional crosslinking agents and protein polymers
11/27/2007CA2391333C Sustained release formulation of a peptide and a copolymer
11/27/2007CA2309380C Viscous compositions containing carbon dioxide
11/27/2007CA2292600C Compositions and methods for inhibiting photoaging of skin
11/27/2007CA2290557C Use of 4-substituted tetrahydropyridines for making medicines acting on tgf-.beta.1
11/22/2007WO2007132948A1 Cinnamoyl compound and use thereof
11/22/2007WO2007132945A1 Cinnamoyl compound and use thereof
11/22/2007WO2007132900A1 Skin moisturizer and therapeutic agent for dermatitis
11/22/2007WO2007132710A1 Bactericidal/preservative agent
11/22/2007WO2007132307A1 Cycloalkylamino acid derivatives and pharmaceutical compositions thereof
11/22/2007WO2007107663A3 Use of (3s)-n-hydroxy-4-({4-[(4-hydroxy-2-butynyl)oxy]phenyl}sulfonyl)-2,2-dimethyl-3-thiomorpholine carboxamide or (s)-n-hydroxy-4-(4-but-2-ynyloxy-benzenesulfonyl) -2,2-dimethyl-thiomorpholine -3-carboxamide for treating inflammatory skin pathologies
11/22/2007WO2007093746A3 Use of muraglitazar for preparing a pharmaceutical composition for treating skin disorders
11/22/2007WO2007093183A3 Use of a compound that enhances gabaa-ergic neurotransmission for the treatment of inflammatory diseases
11/22/2007WO2007071448A3 Synthetic peptides for use as inhibitors of neurotransmitter secretion and as inducers of muscle relaxation
11/22/2007WO2007022412A3 Combination therapy for preventing angiogenesis comprising a inhibitor ofhif-1 and a further anti-angiogenic agent
11/22/2007WO2006057886A8 2-METHYLENE-19,26,27-TRINOR-(20S)-1α-HYDROXYVITAMIN D3 AND ITS USES
11/22/2007WO2005123106A8 Use of n-l-alpha-aspartyl-l-phenylalanine 1-methyl ester to treat sunburn and other burns
11/22/2007WO2000018212A8 Platelet-derived growth factor c, dna coding therefor, and uses thereof
11/22/2007US20070270501 Medicaments for Treating Barrett's Eesophagus
11/22/2007US20070270453 TRICYCLIC MODULATORS OF THE GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-kB ACTIVITY AND USE THEREOF
11/22/2007US20070270451 Methods of preparing pimecrolimus
11/22/2007US20070270441 Combination
11/22/2007US20070270420 Heteroaryl compounds useful as inhibitors of gsk-3
11/22/2007US20070270418 Inhibitors of P38 and Methods of Using the Same
11/22/2007US20070270390 Method of the treament of acne
11/22/2007US20070270382 Composition for Protecting Skin
11/22/2007US20070270370 Novel bicyclonucleoside analogues
11/22/2007US20070270358 Cosmetic and/or Pharmaceutical Composition for the Treatment of the Rosacea
11/22/2007US20070270337 Pharmaceutical Compositions for Preventing or Treating Th1-Mediated Immune Diseases
11/22/2007US20070269538 Method for accelerating secretion of estrogen and regenerating tissue cells of female sexual organs
11/22/2007US20070269537 Skin Condition Improvement Including Acne, Rosacea, and Topical Wounds by Artemisia Annua Extract via Iron Siderophore Trojan Horse Delivery System
11/22/2007US20070269526 Carotenoid Composition and Method for Preparation Thereof
11/22/2007US20070269524 Use of Idrocilamide for the Preparation of a Pharmaceutical Composition of Rosacea
11/22/2007US20070269498 New Dressing Material Promoting Recovery Of Skin Wound
11/22/2007US20070269496 Patch for Reducing Exposure of Skin to Ultraviolet Radiation
11/22/2007US20070269454 Composition for External Use
11/22/2007US20070269387 Moisture-Retaining Agent Comprising Alpha-Glycosyl Glycyrrhizing As An Effective Ingredient And Use Thereof
11/22/2007CA2651629A1 Cycloalkylamino acid derivatives and pharmaceutical compositions thereof
11/21/2007EP1857554A1 Monoclonal and chimeric antibodies specific for human tumor necrosis factor
11/21/2007EP1857553A1 Monoclonal and chimeric antibodies specific for human tumor necrosis factor
11/21/2007EP1857551A2 Cystine-knot polypeptides: cloaked-2 molecules and uses thereof
11/21/2007EP1857466A2 Soluble interleukin-20 receptor
11/21/2007EP1857455A1 Cinnamoyl compound and use thereof
11/21/2007EP1857115A2 Using neural thread proteins to treat tumors and other conditions requiring the removal or destruction of cells
11/21/2007EP1857110A2 Hormone replacement therapy
11/21/2007EP1857109A2 Inhibitors of melanocyte tyrosinase as tropical skin lighteners
11/21/2007EP1856065A1 1,2,4-triazine derivatives, preparation and use thereof in human therapy
11/21/2007EP1856040A2 Novel lipoxygenase inhibitors
11/21/2007EP1856029A1 Crystalline acat inhibitor
11/21/2007EP1855721A1 Method and composition for treating mammalian diseases and injuries caused by the over-expression of peroxynitrite
11/21/2007EP1855709A1 Use of myostatin (gdf-8) antagonists for improving wound healing and preventif fibrotic disease
11/21/2007EP1855692A1 Composition for reducing the exudation of serum proteins
11/21/2007EP1855684A2 Pharmaceutical compositions of the isolated d- enantiomer of the quinazolinone derivative halofuginone
11/21/2007EP1608381B1 Therapeutic and consmetic application for a composition containing lycopene
11/21/2007EP1490077B1 A photoprotective orally administrable composition for skin
11/21/2007EP1482920B1 Compositions containing n-acyl-phosphatidyl-ethanolamines and/or mixtures of n-acyl-ethanolamines with phosphatidic acids or lysophosphatidic acids
11/21/2007EP1458383B1 Heteroaryl substituted pyrazole modulators of metabotropic glutamate receptor-5
1 ... 449 450 451 452 453 454 455 456 457 458 459 460 461 462 463 464 465 466 467 468 469 ... 1065